At Insulet Corporation all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
","datePosted":"2025-04-21T06:59","employmentType":"FULL_TIME","jobLocation":[{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"Acton, MA, USA","addressRegion":null,"addressCountry":"United States"}}],"directApply":false,"hiringOrganization":{"@type":"Organization","name":"Insulet Corporation","sameAs":"https://www.insulet.com/","logo":"https://storage.googleapis.com/simplify-imgs/companies/dc2cf0d7-af5f-4a5c-9c42-8fa0bd0ae04d/logo.png"},"baseSalary":{"@type":"MonetaryAmount","currency":"USD","value":{"@type":"QuantitativeValue","minValue":134475,"maxValue":201712.5,"unitText":"YEAR"}},"identifier":{"@type":"PropertyValue","name":"Insulet Corporation","value":"dc2cf0d7-af5f-4a5c-9c42-8fa0bd0ae04d"}}Full-Time
Develops tubeless insulin delivery systems
$134.5k - $201.7k/yr
Senior
Acton, MA, USA
Must be on-site in Acton, MA 4 days/week; eligible for hybrid working arrangements (requires on-site work from an Insulet office at least 1x/week; may work remotely other days).
Get referrals →
You have ways to get a Insulet Corporation referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 11 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Insulet Corporation focuses on creating medical devices that make life easier for individuals with diabetes and other health conditions. Their main product, the Omnipod Insulin Management System, offers a different approach to insulin delivery compared to traditional methods. The Omnipod is a tubeless, disposable device that can deliver insulin continuously for up to three days without the need for needles. The latest version, the Omnipod 5 Automated Insulin Delivery System, works with a continuous glucose monitor to automatically manage blood sugar levels, eliminating the need for multiple daily injections and fingersticks. Users can control the system through a smartphone or a dedicated controller. Insulet stands out from competitors by providing a simple, wearable solution that integrates technology to enhance diabetes management. The company's goal is to improve the quality of life for people with diabetes by offering convenient and effective insulin delivery options.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Acton, Massachusetts
Founded
2000
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Insulet competes with companies like DexCom, Tandem Diabetes Care, and Masimo Corporation in the diabetes care market.
Insulet raises $444.4M through senior notes to refinance existing convertible debt. Strategic move positions medical device maker for future growth while optimizing capital structure.
Insulet (NASDAQ: PODD) will present results from its multinational RADIANT trial at the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in March 2025.
This video helped Insulet launch its new iPhone app.
Ubiquiti competes with companies like Fair Isaac Corporation, Paylocity Holding Corporation, Monolithic Power Systems, EPAM Systems, and Insulet Corporation.